A critical breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial malignant inhibitor protein is frequently inactivated in many forms of cancer, resulting https://bookmarks4seo.com/story21986525/nanobodies-revive-p53-a-new-hope-for-tumor-management